I. Kovalszky

I. Kovalszky, Z. Suba, J. Barabás, 2007, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Decorin expression in chronic hepatitis C; effect of interferon alpha treatment

I. Kovalszky, K. Jármay, J. Dudás, 2003 .

Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.

I. Kovalszky, G. Ramadori, J. Dudás, 2001, American journal of clinical pathology.

Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.

I. Kovalszky, G. Ramadori, T. Armbrust, 1996, The American journal of pathology.

Leptin‐based glycopeptide induces weight loss and simultaneously restores fertility in animal models

S. Lovas, I. Kovalszky, L. Otvos, 2010, Diabetes, obesity & metabolism.

Marker enzymes of rat chemical hepatocarcinogenesis in human liver tumors

I. Kovalszky, K. Lapis, Z. Schaff, 2008, Pathology & Oncology Research.

Peptide‐based leptin receptor antagonists for cancer treatment and appetite regulation

S. Lovas, I. Kovalszky, R. Hoffmann, 2011, Biopolymers.

Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.

I. Kovalszky, K. Lapis, A. Jeney, 1976, Cancer research.

Serum Levels of Angiogenic Factors and their Prognostic Relevance in Bladder Cancer

I. Kovalszky, S. Ergün, T. Szarvas, 2009, Pathology & Oncology Research.

Regulatory role of kinases and phosphatases on the internalisation of caveolae in HepG2 cells.

I. Kovalszky, A. Kiss, E. Botos, 2007, Micron.

Ocadaic acid treatment alters the intracellular localization of caveolin-1 and caveolin-2 in HepG2 cells

I. Kovalszky, A. Kiss, E. Botos, 2003 .

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2

I. Kovalszky, K. Dobra, B. Péterfia, 2012, PloS one.

Modulation of extracellular matrix gene expression by heparin and endothelial cell growth factor in human smooth muscle cells.

I. Kovalszky, G. R. Dodge, T. Sorger, 1991, Laboratory investigation; a journal of technical methods and pathology.

No mutation but high mRNA expression of Coxsackie-Adenovirus Receptor was observed in both dilated and ischemic cardiomyopathy.

I. Kovalszky, M. Hubay, P. Sótonyi, 2011, Forensic science international.

Proteoglycans in Chronic Liver Disease and Hepatocellular Carcinoma: An Update

I. Kovalszky, Péter Tátrai, 2012 .

Claudins and tricellulin in fibrolamellar hepatocellular carcinoma

P. Schirmacher, I. Kovalszky, A. Kiss, 2011, Virchows Archiv.

An Immunohistochemical Study of Colon Adenomas and Carcinomas: E-cadherin, Syndecan-1, Ets-1

I. Kovalszky, L. Dénes, Z. Pap, 2009, Pathology & Oncology Research.

Invasive growth and topoisomerase‐switch induced by tumorous extracellular matrix in osteosarcoma cell culture

I. Kovalszky, J. Tímár, M. Szendrői, 2005, Cell biology international.

Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer

I. Kovalszky, S. Ergün, C. Niedworok, 2011, Pathology & Oncology Research.

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

B. Hadaschik, I. Kovalszky, H. Reis, 2020, Diagnostics.

Molecular Characteristics of Fibrolamellar Hepatocellular Carcinoma

I. Kovalszky, E. Raso, A. Kiss, 2012, Pathology & Oncology Research.

[Clinical observations in cutan mastocytosis].

I. Kovalszky, S. Kárpáti, M. Marschalkó, 2013, Orvosi hetilap.

Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer

I. Kovalszky, P. Igaz, S. Tóth, 2013, Cellular and Molecular Life Sciences.

Nuclear translocation of heparan sulfate proteoglycans and their functional significance.

I. Kovalszky, A. Hjerpe, K. Dobra, 2014, Biochimica et biophysica acta.

Expression of glycosaminoglycans in cirrhotic liver and hepatocellular carcinoma—a pilot study including etiology

I. Kovalszky, L. Drahos, Lilla Turiák, 2022, Analytical and Bioanalytical Chemistry.

Syndecan-1 - A new piece in B-cell puzzle

I. Kovalszky, L. Kopper, M. Gallai, 1997, Pathology & Oncology Research.

Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia.

I. Kovalszky, J. Bocsi, R. Mihalik, 1997, European journal of cancer.

Original Paper Expression of Syndecan-1 in Human B Cell Chronic Lymphocytic Leukaemia

I. Kovalszky, J. Bocsi, R. Mihalik, 1997 .

Aberrant Expression of Syndecan-1 in Cervical Cancers

I. Kovalszky, K. Karászi, Z. Papp, 2020, Pathology & Oncology Research.

Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas.

I. Kovalszky, G. Borgulya, Z. Suba, 2006, Oral oncology.

Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single‐center experience

I. Kovalszky, M. Varga, E. Sárváry, 2004, Clinical transplantation.

Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice

I. Kovalszky, L. Otvos, J. Wade, 2015, Amino Acids.

Human and experimental hepatocarcinogenesis.

I. Kovalszky, K. Lapis, P. Nagy, 1998, Scandinavian journal of gastroenterology. Supplement.

Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.

A. Szilágyi, K. Kekesi, G. Juhász, 2020, Placenta.

Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?

I. Kovalszky, O. Erez, K. Karászi, 2019, Placenta.

Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome

I. Kovalszky, R. Romero, S. Hassan, 2015, Pathology & Oncology Research.

Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome

I. Kovalszky, R. Romero, S. Hassan, 2013, Virchows Archiv.

The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma

I. Kovalszky, Z. Horváth, A. Kiss, 2020, Biomolecules.

Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation

I. Kovalszky, E. Raso, J. Tímár, 1997, International journal of cancer.

Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14.

I. Kovalszky, G. Szabó, A. Kiss, 2018, Matrix biology : journal of the International Society for Matrix Biology.

Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival

I. Kovalszky, H. Reis, T. Szarvas, 2022, Cancers.

Endogenous enzyme-hydrolyzed fruit of Cirsium brachycephalum: optimal source of the antiproliferative lignan trachelogenin regulating the Wnt/β-catenin signaling pathway in the SW480 colon adenocarcinoma cell line.

I. Kovalszky, I. Molnár-Perl, I. Boldizsár, 2015, Fitoterapia.

Cytokine regulation of syndecan expression in cells of liver origin.

I. Kovalszky, G. Ramadori, T. Knittel, 2000, Cytokine.

Modification of DENA-induced hepatocarcinogenesis by CCl4 cirrhosis. Comparison of the marker enzyme patterns.

I. Kovalszky, K. Lapis, A. Zalatnai, 1992, Carcinogenesis.

Role of proteoglycans in tumor progression

I. Kovalszky, L. Kopper, A. Jeney, 2008, Pathology & Oncology Research.

Morphological and biochemical studies on the effect of agents with liver protecting properties.

I. Kovalszky, B. Szende, K. Szepesházi, 1978, Experimentelle Pathologie.

Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas

R. Pique-Regi, I. Kovalszky, A. Tarca, 2022, International journal of molecular sciences.

[Proteoglycans in the liver].

I. Kovalszky, J. Dudás, Péter Tátrai, 2004, Magyar onkologia.

Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer

I. Kovalszky, P. Igaz, S. Tóth, 2014, Cellular and Molecular Life Sciences.

Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma

I. Kovalszky, G. Ramadori, J. Dudás, 2006, Laboratory Investigation.

Expression of a decorin-like molecule in human melanoma

I. Kovalszky, J. Tímár, J. Dudás, 2009, Pathology & Oncology Research.

Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies

T. Glasz, I. Kovalszky, A. Kiss, 2022, GeroScience.

Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.

I. Kovalszky, J. Tímár, K. Lapis, 2002, Seminars in cancer biology.

Proteoglycans/Glycosaminoglycans: From Basic Research to Clinical Practice

I. Kovalszky, P. Heldin, G. Tzanakakis, 2014, BioMed research international.

Editorial Proteoglycans/Glycosaminoglycans: From Basic Research to Clinical Practice

I. Kovalszky, P. Heldin, G. Tzanakakis, 2014 .

Syndecan-1 in liver pathophysiology.

I. Kovalszky, Péter Tátrai, K. Baghy, 2022, American journal of physiology. Cell physiology.

Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon-alfa-2b treatment.

I. Kovalszky, K. Jármay, J. Lonovics, 2000, Journal of hepatology.

Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells

I. Kovalszky, K. Vékey, J. Kralovánszky, 2016, Cancer Cell International.

Decorin–TGFβ Axis in Hepatic Fibrosis and Cirrhosis

I. Kovalszky, R. Iozzo, K. Baghy, 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Potential markers (enzymes, proteoglycans) for human liver tumors.

I. Kovalszky, Z. Schaff, A. Jeney, 1993, Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma.

A simple and effective enrichment process of the antiproliferative lignan arctigenin based on the endogenous enzymatic hydrolysis of Serratula tinctoria and Arctium lappa fruits

I. Kovalszky, I. Molnár-Perl, I. Boldizsár, 2015 .

Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice

I. Kovalszky, G. Szabó, A. Kiss, 2021, Cancers.

Serum and tissue syndecan-1 levels in renal cell carcinoma

B. Hadaschik, I. Kovalszky, A. Eisenhardt, 2020, Translational andrology and urology.

Alkaline phosphatase activity in human and rat liver tumors.

I. Kovalszky, K. Lapis, J. Kralovánszky, 1991, Oncology.

Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia

S. Drăghici, B. Győrffy, G. Juhász, 2018, Front. Immunol..

BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters?

B. Győrffy, A. Yosepovich, I. Barshack, 2015, Pathobiology.

Altered glycosaminoglycan composition in reactive and neoplastic human liver.

I. Kovalszky, R. Iozzo, K. Lapis, 1990, Biochemical and biophysical research communications.

Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model.

K. Medzihradszky, I. Kovalszky, P. Igaz, 2015, American journal of cancer research.

Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice

I. Kovalszky, R. Iozzo, V. Laszlo, 2011, Laboratory Investigation.

Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.

I. Kovalszky, R. Romero, A. Tarca, 2011, Placenta.

Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

I. Kovalszky, T. Wittmann, K. Jármay, 2014, World journal of gastroenterology.

[Alterations in microRNA expression patterns in liver diseases].

I. Kovalszky, A. Kiss, G. Lendvai, 2010, Orvosi hetilap.

Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1.

I. Kovalszky, G. R. Dodge, O. Mcbride, 1991, Genomics.

Construction of a multiplex mutation hot spot PCR panel: the first step towards colorectal cancer genotyping on the GS Junior platform

I. Csabai, A. Kalmár, B. Molnár, 2017, Journal of Cancer.

Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.

I. Kovalszky, T. Szarvas, P. Riesz, 2007, Oncology reports.

Proteomic identification of membrane-associated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies

I. Kovalszky, L. Drahos, K. Karászi, 2019, PeerJ.

Placental Protein 13 (PP13) – A Placental Immunoregulatory Galectin Protecting Pregnancy

A. Szilágyi, I. Kovalszky, R. Romero, 2014, Front. Immunol..

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma

W. Berger, I. Kovalszky, Z. Lohinai, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors

I. Kovalszky, M. Garami, M. Szendrői, 2013, Cellular Oncology.

The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.

I. Kovalszky, T. Szarvas, Z. Suba, 2006, Virology.

Human clathrin heavy chain (CLTC): partial molecular cloning, expression, and mapping of the gene to human chromosome 17q11-qter.

I. Kovalszky, G. R. Dodge, O. Mcbride, 1991, Genomics.

Utilisation of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues

I. Kovalszky, M. Garami, M. Szendrői, 2012, Journal of Clinical Pathology.

Prevalence of APC and PTEN Alterations in Urachal Cancer

B. Hadaschik, I. Kovalszky, J. Tímár, 2020, Pathology & Oncology Research.

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance

S. Shariat, I. Kovalszky, J. Tímár, 2016, Oncotarget.

Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas

A. Kalmár, B. Molnár, I. Kovalszky, 2015, PloS one.

Chromatin alterations and gene function disorder in MC-29 virus-derived hepatoma.

G. Gyapay, I. Kovalszky, K. Lapis, 1979, Journal of toxicology and environmental health.

Syndecan-1 in Liver Diseases

I. Kovalszky, A. Kiss, K. Karászi, 2019, Pathology & Oncology Research.

Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content

I. Kovalszky, P. Sótonyi, K. Kolev, 2010, Thrombosis research.

Phospholipid Barrier to Fibrinolysis

Kiril Tenekedjiev, Krasimir Kolev, I. Kovalszky, 2004, Journal of Biological Chemistry.

Decorin deficiency promotes hepatic carcinogenesis.

I. Kovalszky, R. Iozzo, K. Kiss, 2014, Matrix biology : journal of the International Society for Matrix Biology.

Transforming growth factor beta alters the expression of heparan sulfate proteoglycan in human colon carcinoma cells.

I. Kovalszky, G. R. Dodge, R. Iozzo, 1990, The Journal of biological chemistry.

Chronic Hyperglycemia Induces Trans-Differentiation of Human Pancreatic Stellate Cells and Enhances the Malignant Molecular Communication with Human Pancreatic Cancer Cells

R. Jesenofsky, I. Kovalszky, Z. Tulassay, 2015, PloS one.

Curcumin targets fibroblast–tumor cell interactions in oral squamous cell carcinoma

I. Kovalszky, H. Riechelmann, J. Dudás, 2013, Experimental cell research.

Decorin in the Tumor Microenvironment.

I. Kovalszky, Péter Tátrai, K. Baghy, 2020, Advances in experimental medicine and biology.

Tumor-specific inhibitory action of decorin on different hepatoma cell lines.

I. Kovalszky, Z. Horváth, L. Szilák, 2019, Cellular signalling.

Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor

I. Kovalszky, G. Ramadori, T. Szarvas, 2017, Pathology & Oncology Research.

EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study

Z. Szallasi, V. Téglási, O. Pipek, 2021, Translational lung cancer research.

Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse

I. Kovalszky, K. Baghy, Krisztina Egedi, 2018, BMC Cancer.

Salt gradient chromatographic separation of chondroitin sulfate disaccharides.

I. Kovalszky, L. Drahos, K. Vékey, 2020, Journal of chromatography. A.

Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress

I. Kovalszky, K. Kiss, K. Baghy, 2018, Pathology & Oncology Research.

Extracellular matrix functions in lung cancer.

I. Kovalszky, M. Götte, 2018, Matrix biology : journal of the International Society for Matrix Biology.

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.

B. Ghanim, W. Berger, I. Kovalszky, 2014, European journal of cancer.

Genome-Wide Screening of Genes Regulated by DNA Methylation in Colon Cancer Development

I. Csabai, A. Kalmár, B. Molnár, 2012, PloS one.

Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis

I. Kovalszky, A. Kiss, G. Lendvai, 2018, Pathology & Oncology Research.

Myosin: a noncovalent stabilizer of fibrin in the process of clot dissolution.

Kiril Tenekedjiev, Krasimir Kolev, Katalin Ajtai, 2003, Blood.

The effects of sulfated hyaluronan in breast, lung and colorectal carcinoma and monocytes/macrophages cells: Its role in angiogenesis and tumor progression

I. Kovalszky, L. Alaniz, D. Galesso, 2022, IUBMB life.

DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer

A. Kalmár, B. Molnár, I. Kovalszky, 2015, BMC Cancer.

Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome

I. Kovalszky, R. Romero, A. Tarca, 2008, Virchows Archiv.

Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis

I. Kovalszky, L. Otvos, J. Wade, 2011, Peptides.

Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1

I. Kovalszky, T. Szarvas, K. Karászi, 2020, Biomolecules.

Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration.

I. Kovalszky, P. Lakatos, F. Szalay, 2012, Anticancer research.

NSCLC molecular testing in Central and Eastern European countries

W. Olszewski, R. Dziadziuszko, I. Kovalszky, 2018, BMC Cancer.

Development of second generation peptides modulating cellular adiponectin receptor responses

S. Lovas, I. Kovalszky, R. Hoffmann, 2014, Front. Chem..

Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas

I. Kovalszky, P. Igaz, S. Czirják, 2017, Pathology & Oncology Research.

Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia

I. Kovalszky, A. Kiss, Ilona Kovalszky, 2009, Pathology & Oncology Research.

Agrin and CD34 Immunohistochemistry for the Discrimination of Benign Versus Malignant Hepatocellular Lesions

P. Schirmacher, I. Kovalszky, A. Kiss, 2009, The American journal of surgical pathology.

The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor

I. Kovalszky, S. Vetter, R. Hoffmann, 2014, Amino Acids.

Soluble syndecan‐1 (SDC1) serum level as an independent pre‐operative predictor of cancer‐specific survival in prostate cancer

I. Kovalszky, K. Schmid, H. Reis, 2016, The Prostate.

Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.

I. Kovalszky, V. Laszlo, Z. Papp, 2006, Gynecologic oncology.

Design and development of a peptide-based adiponectin receptor agonist for cancer treatment

Ralf Hoffmann, Laszlo Otvos, John Wade, 2011, BMC biotechnology.

Expression of Matrilin-2 in Liver Cirrhosis and Hepatocellular Carcinoma

I. Kovalszky, F. Deák, A. Kiss, 2008, Pathology & Oncology Research.

Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse

I. Kovalszky, K. Baghy, Krisztina Egedi, 2018, BMC Cancer.

Two ways of epigenetic silencing of TFPI2 in cervical cancer

I. Kovalszky, K. Karászi, J. Dudás, 2020, PloS one.

Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.

S. Shariat, I. Kovalszky, G. Kramer, 2014, Human pathology.

Reduction of apoptosis of in vitro cultured peripheral blood lymphocytes of HIV positive individuals by thymocartin

I. Kovalszky, B. Szende, A. Horváth, 1997 .

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer

I. Kovalszky, M. Götte, K. Baghy, 2023, Cancers.

SPOCK1 with unexpected function. The start of a new career.

I. Kovalszky, Péter Tátrai, K. Baghy, 2022, American journal of physiology. Cell physiology.

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

I. Kovalszky, Z. Lohinai, E. Raso, 2017, Scientific Reports.

Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors

I. Kovalszky, A. Kiss, G. Lendvai, 2020, Scientific Reports.

[Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].

I. Kovalszky, B. Péterfia, L. Szilák, 2006, Magyar onkologia.

Heparin and Liver Heparan Sulfate Can Rescue Hepatoma Cells from Topotecan Action

I. Kovalszky, J. Dudás, J. Bocsi, 2014, BioMed research international.

Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer

B. Hadaschik, I. Kovalszky, H. Reis, 2018, Pathology & Oncology Research.

Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice

I. Kovalszky, L. Otvos, J. Wade, 2015, Amino Acids.

Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes

S. Thorgeirsson, I. Kovalszky, V. Laszlo, 2008, Histochemistry and Cell Biology.

Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer.

I. Kovalszky, P. Igaz, K. Rácz, 2016, American journal of cancer research.

Optimization of adiponectin‐derived peptides for inhibition of cancer cell growth and signaling

S. Lovas, I. Kovalszky, R. Hoffmann, 2015, Biopolymers.

The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor

Ralf Hoffmann, Nina Bionda, John D. Wade, 2013, Amino Acids.

Modification of pathobiological events by potential hepatopharmacological agents

I. Kovalszky, B. Szende, K. Lapis, 2007, InflammoPharmacology.

KOLEV et al MYOSIN: A NON-COVALENT STABILIZER OF FIBRIN Scientific section designation: HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Myosin: a non-covalent stabilizer of fibrin in the process of clot dissolution

I. Kovalszky, K. Tenekedjiev, K. Kolev, 2003 .

Chemodiversity of Cirsium fruits: Antiproliferative lignans, neolignans and sesquineolignans as chemotaxonomic markers.

I. Kovalszky, S. Béni, I. Molnár-Perl, 2018, Fitoterapia.

Fatty acylation of heparan sulfate proteoglycan from human colon carcinoma cells.

I. Kovalszky, G. R. Dodge, R. Iozzo, 1990, The Journal of biological chemistry.

Lack of Matrilin-2 Favors Liver Tumor Development via Erk1/2 and GSK-3β Pathways In Vivo

I. Kovalszky, F. Deák, B. Péterfia, 2014, PloS one.

Compositional Analysis of Glycosaminoglycans in Different Lung Cancer Types—A Pilot Study

I. Kovalszky, Dániel Szabó, Lilla Turiák, 2023, International journal of molecular sciences.

In situ and peripheral biomarkers of development of colorectal cancer

I. Kovalszky, K. Tóth, 2015 .

Inhibitory Effect of (2R)-1-(1-Benzofuran-2-yl)-N-propylpentan-2-amine on Lung Adenocarcinoma

I. Kovalszky, K. Baghy, Z. Schaff, 2019, Pathology & Oncology Research.

Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors

I. Kovalszky, M. Garami, M. Szendrői, 2013, Cellular Oncology.

New diagnostic methods of urological tumors

I. Kovalszky, E. Székely, 2012 .

Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression

I. Kovalszky, J. Dudás, Z. Papp, 2015, BMC Cancer.

Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression

I. Kovalszky, K. Rácz, A. Patócs, 2016, BMC Genomics.

Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts

I. Kovalszky, K. Pálóczi, Lilla Turiák, 2023, International journal of molecular sciences.

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.

B. Ghanim, W. Berger, I. Kovalszky, 2014, European journal of cancer.

Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.

I. Kovalszky, A. Kiss, Péter Tátrai, 2010, Human pathology.

Ultrastructure and composition of thrombi in coronary and peripheral artery disease: correlations with clinical and laboratory findings.

I. Kovalszky, K. Tenekedjiev, B. Merkely, 2015, Thrombosis research.

Insights into the Tumor Microenvironment—Components, Functions and Therapeutics

I. Kovalszky, Andrea Reszegi, Kornélia Baghy, 2023, International journal of molecular sciences.